Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin

被引：0
|
作者：
Cheryl A Sherman-Baust
Kevin G Becker
William H Wood III
Yongqing Zhang
Patrice J Morin
机构：
[1] National Institute on Aging,Laboratory of Molecular Biology and Immunology
[2] National Institute on Aging,Research Resource Branch
[3] Johns Hopkins Medical Institutions,Department of Pathology
来源：
Journal of Ovarian Research | / 4卷
关键词：
Ovarian Cancer; Paclitaxel; Doxorubicin; Drug Resistance; Ovarian Cancer Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
    Sherman-Baust, Cheryl A.
    Becker, Kevin G.
    Wood, William H.
    Zhang, Yongqing
    Morin, Patrice J.
    JOURNAL OF OVARIAN RESEARCH, 2011, 4
  • [2] APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
    Mohell, N.
    Alfredsson, J.
    Fransson, A.
    Uustalu, M.
    Bystrom, S.
    Gullbo, J.
    Hallberg, A.
    Bykov, V. J. N.
    Bjorklund, U.
    Wiman, K. G.
    CELL DEATH & DISEASE, 2015, 6 : e1794 - e1794
  • [3] APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
    N Mohell
    J Alfredsson
    Å Fransson
    M Uustalu
    S Byström
    J Gullbo
    A Hallberg
    V J N Bykov
    U Björklund
    K G Wiman
    Cell Death & Disease, 2015, 6 : e1794 - e1794
  • [4] Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines
    Scöhndorf, T
    Neumann, R
    Benz, C
    Becker, M
    Riffelmann, M
    Göhring, UJ
    Sartorius, J
    von König, CHW
    Breidenbach, M
    Valter, MM
    Hoopmann, M
    Di Nicolantonio, F
    Kurbacher, CM
    CHEMOSENSITIVITY TESTING IN ONCOLOGY, 2003, 161 : 111 - 116
  • [5] Gene expression profile of cisplatin resistance in ovarian cancer cell lines
    Gonda, T
    Walker, R
    Sood, A
    Hendrix, M
    Meltzer, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S158 - S158
  • [6] HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
    Ribeiro, J. R.
    Schorl, C.
    Yano, N.
    Romano, N.
    Kim, K. K.
    Singh, R. K.
    Moore, R. G.
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [7] HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
    J. R. Ribeiro
    C. Schorl
    N. Yano
    N. Romano
    K. K. Kim
    R. K. Singh
    R. G. Moore
    Journal of Ovarian Research, 9
  • [8] Paclitaxel and cisplatin in ovarian cancer
    Torri, V
    Harper, PG
    Colombo, N
    Sandercock, J
    Parmar, MKB
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) : 2349 - 2349
  • [9] Models of Ovarian Cancer Cell Resistance to Doxorubicin and Cisplatin.
    Caffrey, P.
    Gasper, L.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [10] Unique expression patterns for paclitaxel, doxorubicin and cisplatin in breast carcinoma cells
    Fei Yang
    Gerald Manorek
    Gerrit Los
    Nature Genetics, 2001, 27 (Suppl 4) : 70 - 70
12345